# GLP-1 Drugs Recalled Amid Safety Concerns

> FDA recalls Apothecary Pharma's compounded GLP-1 injections after contamination risks.
- Title: GLP-1 Drugs Recalled Amid Safety Concerns · The Boston Globe
- Summary: FDA recalls Apothecary Pharma's compounded GLP-1 injections after contamination risks. FDA recalls 22 lots of Apothecary Pharma's compounded GLP-1 drugs due…
- Keywords: glp-1, compounded drugs, apothecary pharma, fda, recall, tirzepatide, weight loss drugs, news, local, Drugs, Recalled, Safety
- Source: The Boston Globe — https://bostonglobe.com/2026/10/21/business/glp-1-alternative-drugs-face-nationwide-recall
- Read time: 1 min
- Topics: glp-1, compounded drugs, apothecary pharma, fda, recall, tirzepatide, weight loss drugs, news, local
## FDA Recall Announcement
FDA officials announced a nationwide recall of an injectable medication found in many compounded GLP-1 drugs.
## Apothecary Pharma Recall
Apothecary Pharma LLC issued a voluntary recall on dozens of its tirzepatide injections on sept. 24.
## Recall Scope
The recall impacts 22 lots of compounded GLP-1s, which are not FDA approved alternatives.
## FDA's Safety Concerns
FDA warns compounded GLP-1s could contain contaminants including microbes and unapproved ingredients.
## Recall Status Update
FDA classified the recall as presenting only a 'remote' possibility of serious health consequences.
## Patient Guidance
FDA advises patients not to use compounded GLP-1s unless name-brand drugs cannot meet medical needs.
## Key takeaway

FDA recalls 22 lots of Apothecary Pharma's compounded GLP-1 drugs due to contamination risks.